News

FDA adds new blue food dye from gardenia fruit
The U.S. Food and Drug Administration on Monday approved the use of a new blue color additive from the gardenia fruit the ...
The FDA Just Approved Another Natural Food Dye for Use in Several Common Snacks and Drinks
According to today's announcement from the FDA, an estimated 40% of the food industry has committed to voluntarily phasing ...
FDA approves new blue food dye derived from gardenia fruit
The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering ...
FDA Approves Gardenia-Based Blue Dye for Use in Foods and Drinks
TUESDAY, July 15, 2025 (HealthDay News) — A natural blue food coloring made from gardenia fruit has been approved by the U.S.
ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
FDA confirmed that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with ...
Caranx Medical’s AI TAVI-TAVR software gains FDA approval
TAVIPILOT Soft is said to be a ‘world-first’ provision for real-time surgical guidance during TAVI and TAVR procedures.
FDA staff raises eye damage concerns for GSK's blood cancer drug
The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug Blenrep, when used in combination with other treatments, may cause eye damage in ...
FDA approves Kerendia for heart failure with ejection fraction of 40% or higher
Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...
Food Business News3h
FDA approves another naturally-derived color
The US Food and Drug Administration has approved gardenia (genipin) blue color for use in certain foods and beverages, making it the fourth color derived from natur ...
News-Medical.Net36m
New UAB-developed gene therapy for ALS receives orphan drug designation
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral ...
ALS News Today1h
ALS gene therapy candidate KLTO‑202 wins orphan drug status
KLTO‑202 is an experimental gene therapy that would deliver the instructions for a protein that may reduce inflammation and oxidative stress.
ProKidney stock soars after FDA confirms accelerated approval pathway
Investing.com -- ProKidney Corp (NASDAQ: PROK) stock jumped as high as 12% after the company announced that the U.S. Food and Drug Administration (FDA) has confirmed an accelerated approval pathway ...